Glutathione, iron and Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical Pharmacology

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(02)01174-7PMID 12213603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

  2005cited by this paper
• Deoletion of brain glutathione is accompanied by impaired micochondrial function and decreased N-acetyl aspartate concentration

  2004cited by this paper
• Glutathione decreases in dopaminergic PC12 cells interfere
with the ubiquitin protein degradation pathway: relevance 
for Parkinson's disease?

  2002cited by this paper
• Parkinson's disease--redox mechanisms.

  2001cited by this paper
• Heredity in Parkinson's disease: new findings.

  2001cited by this paper
• Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?

  2001cited by this paper
• Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

  2001cited by this paper
• Iron and neurodegenerative disorders.

  2001cited by this paper
• Gene expression analysis in N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R‐apomorphine

  2001cited by this paper
• Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?

  2001cited by this paper
• Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?

  2000cited by this paper
• cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease.

  2000cited by this paper
• Preservation of midbrain catecholaminergic neurons in very old human subjects.

  2000cited by this paper
• Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

  2000cited by this paper
• Impaired iron homeostasis in Parkinson's disease.

  2000cited by this paper
• The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

  2000cited by this paper
• Glutathione metabolism in brain

  2000cited by this paper
• Metabolism and functions of glutathione in brain.

  2000cited by this paper
• Glutathione, oxidative stress and neurodegeneration.

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity

  2000cited by this paper
• Glutathione synthesis is essential for mouse development but not for cell growth in culture.

  2000cited by this paper
• The genetics of Parkinson's disease.

  2000cited by this paper
• Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species.

  2000cited by this paper
• Genetics of Parkinson's Disease

  2000cited by this paper
• Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease.

  2000cited by this paper
• Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

  2000cited by this paper
• What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?

  2000cited by this paper
• Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

  1999cited by this paper
• Circulation and Energy Metabolism of the Brain

  1999cited by this paper
• The pharmacokinetics and pharmacodynamics of Procysteine in amyotrophic lateral sclerosis

  1999cited by this paper
• Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

  1999cited by this paper
• Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy.

  1999cited by this paper
• Gene expression and thiol redox state.

  1999cited by this paper
• Glutathione S-transferases--a review.

  1999cited by this paper
• Biologic and pharmacologic regulation of mammalian glutathione synthesis.

  1999cited by this paper
• MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

  1999cited by this paper
• Antioxidant and redox regulation of genes

  1999cited by this paper
• Copper(II)-induced self-oligomerization of alpha-synuclein.

  1999cited by this paper
• Gene expression and the thiol redox state.

  1999cited by this paper
• Immunocytochemical demonstration of reduced glutathione in neurons of rat forebrain.

  1999cited by this paper
• Nitrosative stress.

  1999cited by this paper
• GSH Transport in Immortalized Mouse Brain Endothelial Cells

  1999cited by this paper
• The role of glutathione in the regulation of apoptosis

  1999cited by this paper
• Glutathione and Signal Transduction in the Mammalian CNS

  1999cited by this paper
• BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity.

  1999cited by this paper
• S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione.

  1999cited by this paper
• Glutathione and its role in cellular functions.

  1999cited by this paper
• Brain γ‐glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional‐specific enzyme activities and glutathione levels

  1999cited by this paper
• Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro

  1999cited by this paper
• Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India

  1998cited by this paper
• Genetics of Parkinson's disease

  1998cited by this paper
• Energy Thresholds in Brain Mitochondria

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• The skin's antioxidant systems.

  1998cited by this paper
• Thiol Oxidation and Loss of Mitochondrial Complex I Precede Excitatory Amino Acid-Mediated Neurodegeneration

  1998cited by this paper
• The skin's antioxidant systems.

  1998cited by this paper
• In Vitro Studies of Ferritin Iron Release and Neurotoxicity

  1998cited by this paper
• Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra

  1997cited by this paper
• Mitochondrial Complex I defects in aging

  1997cited by this paper
• The Lipid Peroxidation Product, 4‐Hydroxy‐2‐trans‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins

  1997cited by this paper
• In vivo monitoring of glutathione and cysteine in rat caudate nucleus using microdialysis on-line with capillary zone electrophoresis-laser induced fluorescence detection.

  1997cited by this paper
• Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death.

  1997cited by this paper
• Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's Disease

  1997cited by this paper
• Gamma-glutamyl transpeptidase, a blood-brain barrier associated membrane protein. Splitting peptides to transport amino acids.

  1997cited by this paper
• Understanding Parkinson's disease.

  1997cited by this paper
• γ-Glutamyl Transpeptidase, a Blood-Brain Barrier Associated Membrane Protein

  1997cited by this paper
• Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.

  1996cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• Superoxide accelerates DNA damage by elevating free-iron levels.

  1996cited by this paper
• Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones

  1996cited by this paper
• Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.

  1996cited by this paper
• The role of iron-sulfur clusters in in vivo hydroxyl radical production.

  1996cited by this paper
• Detoxification of reactive aldehydes in mitochondria: Effects of age and dietary restriction

  1996cited by this paper
• Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine

  1996cited by this paper
• Reduced intravenous glutathione in the treatment of early Parkinson's disease.

  1996cited by this paper
• Oxidative Stress, Caloric Restriction, and Aging

  1996cited by this paper
• GSH transporters: molecular characterization and role in GSH homeostasis.

  1996cited by this paper
• Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

  1996cited by this paper
• Effect of Buthionine Sulfoximine, a Synthesis Inhibitor of the Antioxidant Glutathione, on the Murine Nigrostriatal Neurons

  1996cited by this paper
• Age‐related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain

  1995cited by this paper
• MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice.

  1995cited by this paper
• Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice.

  1995cited by this paper
• Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease

  1995cited by this paper
• Glutathione in Health and Disease: Pharmacotherapeutic Issues

  1995cited by this paper
• Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

  1995cited by this paper
• Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease.

  1995cited by this paper
• Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

  1995cited by this paper
• Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

  1995cited by this paper
• Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis

  1994cited by this paper
• Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study.

  1994cited by this paper
• Increased Intra‐ and Extracellular Concentrations of γ‐Glutamylglutamate and Related Dipeptides in the Ischemic Rat Striatum: Involvement of γ‐Glutamyl Transpeptidase

  1994cited by this paper
• Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

  1994cited by this paper
• Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

  1994cited by this paper
• Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

  1994cited by this paper
• Determination of extracellular glutathione in rat brain by microdialysis and high-performance liquid chromatography with fluorescence detection.

  1994cited by this paper
• Glutathione‐related enzymes in brain in Parkinson's disease

  1994cited by this paper

• Imidazopyridine Based Fluorescent Turn-Off Sensor for Selective Recognition of Fe3+ Ions and its Application in Test Strips

  2025cites this paper
• Mechanisms and targeted treatments of cobalt-encephalopathy from cobalt-chromium orthopedic implants.

  2025cites this paper
• Facile Biological Oxidation of Dopamine to 6-Hydroxydopamine p-Quinone in a Sequential Two-Step Process: Implications for Parkinson's Disease.

  2025cites this paper
• Study of Nootropic Effect of Improved Nano Formulation Version of Levodopa in a Rat Model of Parkinson’s Disease Induced by 6-Hydroxydopamine.

  2024cites this paper
• Assessing the effects of N-acetyl cysteine on growth, antioxidant and immune response in tilapia (Oreochromis niloticus) under different regimes of stocking densities

  2024cites this paper
• Will the antioxidant supplements impact the mitigation of oxidative stress in Parkinson's disease?

  2024cites this paper
• Oxidative Stress-mediated Lipid Peroxidation-derived Lipid Aldehydes in the Pathophysiology of Neurodegenerative Diseases

  2024cites this paper
• Transcriptome-based biomarker prediction for Parkinson’s disease using genome-scale metabolic modeling

  2024cites this paper
• Novel N-rich porous organic polymers for reversible iodine capture and selective detecting of Fe (III)

  2024cites this paper
• Effects of Phoenix dactylifera against Streptozotocin-Aluminium Chloride Induced Alzheimer's Rats and Their In Silico Study

  2023cites this paper
• Engineering Atomically Dispersed Cu–N1S2 Sites via Chemical Vapor Deposition to Boost Enzyme‐Like Activity for Efficient Tumor Therapy

  2023cites this paper
• Divulging the Intricacies of Crosstalk Between NF-kB and Nrf-2/Keap1 Pathway in the Treatment of Arthritis by Dimethyl Fumarate

  2023cites this paper
• Current Perspectives: Obesity and Neurodegeneration - Links and Risks

  2023cites this paper
• Copper Modulates Adult Neurogenesis in Brain Subventricular Zone

  2022cites this paper
• Predicting Parkinson's Disease Progression: Evaluation of Ensemble Methods in Machine Learning

  2022cites this paper
• Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases

  2022cites this paper
• Exploring multifunctional antioxidants as potential agents for management of neurological disorders

  2022cites this paper
• Evaluation of Antioxidants in Discrete Regions of Brain after the Transplantation of Human Amniotic Epithelial Cells in 2,4,5-Trihydroxyphenylethylamine-lesioned Wistar Albino Rats

  2022cites this paper
• Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson’s Disease

  2021cites this paper
• Remodeling of Arctic char (Salvelinus alpinus) lipidome under a stimulated scenario of Arctic warming

  2021cites this paper
• Oxindole-curcumin hybrid compound enhances the transcription of γ-glutamylcysteine ligase.

  2021cites this paper
• Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders

  2021cites this paper
• EFEITO ANTIOXIDANTE DO ÁCIDO LIPÓICO EM LESÕES CUTÂNEAS DE RATOS DIABETICOS INDUZIDOS POR ALOXANO

  2021cites this paper
• Rhodamine‐Based Fluorescence ‘Turn‐On’ Chemosensor: Detection of Fe 3+ Ion in Aqueous Medium and MCF‐7 Live Cells

  2021cites this paper
• Melatonin for the prevention of fetal injury associated with intrauterine inflammation

  2021cites this paper
• A Combined Drug Treatment That Reduces Mitochondrial Iron and Reactive Oxygen Levels Recovers Insulin Secretion in NAF-1-Deficient Pancreatic Cells

  2021cites this paper
• Natural antioxidants in the management of Parkinson's disease: Review of evidence from cell line and animal models.

  2021cites this paper
• Milk intake enhances cerebral antioxidant (glutathione) concentration in older adults: A randomized controlled intervention study

  2021cites this paper
• 6-Shogaol Exerts a Neuroprotective Factor in Offspring after Maternal Immune Activation in Rats

  2021cites this paper
• Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?

  2021cites this paper
• A multifunctional selective fluorescent chemosensor for detection of Ga3+, In3+ and Fe3+ in different solvents

  2021cites this paper
• Nesfatin-1 Ameliorate Learning and Memory Deficit via Inhibiting Apoptosis and Neuroinflammation Following Ethanol-Induced Neurotoxicity in Early Postnatal Rats

  2020cites this paper
• Lipids in the Treatment of Neurodegenerative Diseases

  2020cites this paper
• Beneficial Effects of Coconut Oil in Treatment of Parkinson’s Disease

  2020cites this paper
• Parkinson’s Disease

  2020cites this paper
• Potential use of glutathione as a treatment for Parkinson's disease

  2020influential citation
• A Novel Fluorescent Probe Based on Pyrazole-Pyrazoline for Fe (III) Ions Recognition

  2020cites this paper
• Beneficial Effects of Coconut Oil in Treatment of Parkinson’s Disease

  2020cites this paper
• Chemopreventive activity of Hydroethanolic Murraya koenigii leaves extract (HEMKLE) against chemically induced skin carcinogenesis in mice.

  2020cites this paper
• Nesfatin-1 Ameliorate Learning and Memory Deficit via Inhibiting Apoptosis and Neuroinflammation Following Ethanol-Induced Neurotoxicity in Early Postnatal Rats

  2020cites this paper
• Effects of glutathione S-transferase M1 and T1 deletions on Parkinson's disease risk among a North African population.

  2020cites this paper
• Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation

  2020cites this paper
• Parkinson's Disease-Induced Zebrafish Models: Focussing on Oxidative Stress Implications and Sleep Processes

  2020cites this paper
• Neurodegenerative Diseases: Potential Effect of Glutathione

  2020cites this paper
• The role of magnetic fields in neurodegenerative diseases

  2020cites this paper
• Neurological effects of subchronic exposure to dioctyl phthalate (DOP), lead, and arsenic, individual and mixtures, in immature mice

  2020cites this paper
• Iron is Responsible for Production of Reactive Oxygen Species Regulating Vasopressin Expression in the Mouse Paraventricular Nucleus

  2019cites this paper
• The ability of three African herbal remedies to offer protection against an in vitro model of Parkinson’s disease

  2019cites this paper
• Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1B9 model

  2019cites this paper
• Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review.

  2019cites this paper
• The Effect of Alpha-Tocopherol on Morphine Tolerance-induced Expression of c-fos Proto-oncogene from a Biotechnological Perspective.

  2019cites this paper
• Diet and medical foods in Parkinson’s disease

  2019cites this paper
• Differentiating the Substantia Nigra and Ventral Tegmental Area in Early-stage Parkinson's Disease Using Iron Imaging

  2019cites this paper
• Nootropic effect of neferine on aluminium chloride–induced Alzheimer's disease in experimental models

  2019cites this paper
• The Role of Xenobiotics and Trace Metals in Parkinson’s Disease

  2019cites this paper
• The Analysis of Glutathione Level and Superoxide Dismutase Activity in Normal and Preeclampsia Pregnant

  2019cites this paper
• Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences

  2019cites this paper
• Pharmacological Effects of Curcuminoids in Neurological Disorders

  2019cites this paper
• Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification.

  2019cites this paper
• Exposure to Pesticides and Welding Hastens the Age-at-Onset of Parkinson’s Disease

  2019cites this paper
• Oxidative stress mediated neurodegeneration; A cellular perspective

  2019cites this paper
• High fat diet deteriorates the memory impairment induced by arsenic in mice: a sub chronic in vivo study

  2019cites this paper
• Oxidative stress and neurodegeneration: the involvement of iron

  2018cites this paper
• Selective and Mechanically Robust Sensors for Electrochemical Measurements of Real-Time Hydrogen Peroxide Dynamics in Vivo.

  2018cites this paper
• Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson's Disease: Current Progress and Future Perspectives.

  2018cites this paper
• Cortex and hippocampus DNA epigenetic response to a long-term arsenic exposure via drinking water.

  2018cites this paper
• Redox imbalance caused by pesticides: a review of OPENTOX-related research

  2018cites this paper
• Neuroprotective effect of phytic acid in Parkinson ' s disease

  2018cites this paper
• Efeito da crisina sobre as alterações comportamentais e neuroquímicos em um modelo da doença de parkinson causada pela 6-hidroxidopamina em camundongos

  2018cites this paper
• Molecular Mechanisms Underlying Oxytosis

  2018cites this paper
• IDH2 deficiency accelerates skin pigmentation in mice via enhancing melanogenesis

  2018cites this paper
• DNA versus RNA oxidation in Parkinson's disease: Which is more important?

  2018cites this paper
• Neuroprotective Role of N-acetylcysteine against Learning Deficits and Altered Brain Neurotransmitters in Rat Pups Subjected to Prenatal Stress

  2018cites this paper
• Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model

  2017cites this paper
• Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis

  2017cites this paper
• The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2

  2017cites this paper
• Fluoride Alteration of [3H]Glucose Uptake in Wistar Rat Brain and Peripheral Tissues

  2017cites this paper
• Idh2 deficiency accelerates renal dysfunction in aged mice.

  2017cites this paper
• Anti-depressant and anxiolytic potential of Acacia hydaspica R. Parker aerial parts extract: Modulation of brain antioxidant enzyme status

  2017cites this paper
• Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease

  2017cites this paper
• Astroglia as a cellular target for neuroprotection and treatment of neuro‐psychiatric disorders

  2017cites this paper
• Small molecule probes for cellular death machines.

  2017cites this paper
• Evaluation of Neuroprotective Effect of Barleria Prionitis Linn in Animal Models of Parkinson’s Disease

  2017cites this paper
• Idh2 Deficiency Exacerbates Acrolein-Induced Lung Injury through Mitochondrial Redox Environment Deterioration

  2017cites this paper
• Alzheimer's Disease and Natural Products: Future Regimens Emerging from Nature.

  2017cites this paper
• Increased susceptibility of IDH2-deficient mice to dextran sodium sulfate-induced colitis

  2017cites this paper
• Assessment of the effect of selected African plants on an in vitro model of Parkinson's disease

  2017influential citation
• Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform

  2017influential citation
• Mitochondrion-Mediated Apoptosis Induced by Acrylamide is Regulated by a Balance Between Nrf2 Antioxidant and MAPK Signaling Pathways in PC12 Cells

  2017cites this paper
• Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.

  2016cites this paper
• A New Schiff Base Chemodosimeter: Selective Colorimetric and Fluorescent Detection of Fe (III) Ion

  2016cites this paper
• The influence of pro-longevity gene Gclc overexpression on the age-dependent changes in Drosophila transcriptome and biological functions

  2016cites this paper
• The Thioredoxins Protein System: a Key Target in Perinatal Asphyxia

  2016influential citation
• Evidence for a role for the putative Drosophila hGRX1 orthologue in copper homeostasis

  2016cites this paper
• Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease

  2016cites this paper
• Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View

  2016cites this paper
• The neurotoxicity of iron, copper and cobalt in Parkinson’s disease through ROS-mediated mechanisms

  2016cites this paper
• Dopamine (DA) Dependent Toxicity Relevant to DA Neuron Degeneration in Parkinson’s Disease (PD)

  2016cites this paper
• Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value

  2016cites this paper
• Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with schizophrenia: A case-control study in a Tunisian population

  2016cites this paper